Product Images Benzonatate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 2 images provide visual information about the product associated with Benzonatate NDC 10135-632 by Marlex Pharmaceuticals Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The structural formula for Benzonatate, a non-narcotic antitussive agent, is 2, 5, 8, 11, 14, 17, 20, 23, 26- nonaoxaoctacosan-28-yl p-(butylamino) benzoate; with a molecular weight of 603.7. - benzonatate capsules 01

The structural formula for Benzonatate, a non-narcotic antitussive agent, is 2, 5, 8, 11, 14, 17, 20, 23, 26- nonaoxaoctacosan-28-yl p-(butylamino) benzoate; with a molecular weight of 603.7. - benzonatate capsules 01

PRINCIPAL DISPLAY PANELBenzonatateCapsules, USP200 mg500 CAPSULESRx Only - benzonatate capsules 02

PRINCIPAL DISPLAY PANELBenzonatateCapsules, USP200 mg500 CAPSULESRx Only - benzonatate capsules 02

This is a medication called Benzonatate which is usually taken as per the information provided in the package outsert. Each capsule includes 200 mg of Benzonatate, USP. The medication should be stored between 20° to 25°C (68° to 77°F) excursions. It is suggested to keep the capsules tightly closed and protect them from light by storing them in a light-resistant container as defined by USP guidelines. This medication is produced by a company called Wearkex Phamacescals, Inc located in New Castle, DE. This specific package contains 500 capsules, and the revision date is October 2017.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.